Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.
about
G Protein-Coupled Receptors in CancerNew Findings on Breast Cancer Stem Cells: A ReviewCXCR4 in breast cancer: oncogenic role and therapeutic targetingA meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancerImmunohistochemical expression of CXCR4 on breast cancer and its clinical significanceThe hematopoietic chemokine CXCL12 promotes integration of human endothelial colony forming cell-derived cells into immature vessel networksMolecular and pathogenetic aspects of tumor budding in colorectal cancerEstablishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cellsEctopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cellsRecent advances in antimultiple myeloma drug development.Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue.Function of chemokine (CXC motif) ligand 12 in periodontal ligament fibroblasts.Cancer metastasis: enactment of the script for human reproductive drama.A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature).CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple MyelomaResponse assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavitiesThe best of both worlds - managing the cancer, saving the bone.The role of chemoattractant receptors in shaping the tumor microenvironment.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.Structural analysis of a novel small molecule ligand bound to the CXCL12 chemokine.ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxisChemokine signaling in development and disease.Clinicopathological significance of CXCR4 in non-small cell lung cancer.Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice.Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma.Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imagingBypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control.In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axisEffects of the ninein-like protein centrosomal protein on breast cancer cell invasion and migration.SDF-1alpha concentration dependent modulation of RhoA and Rac1 modifies breast cancer and stromal cells interaction.Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphomaCXCR4 silencing inhibits invasion and migration of human laryngeal cancer Hep-2 cellsExpression of SOCS1 and CXCL12 Proteins in Primary Breast Cancer Are Associated with Presence of Circulating Tumor Cells in Peripheral BloodBone metastasis and the metastatic niche.Effect of human cytomegalovirus (HCMV) US27 on CXCR4 receptor internalization measured by fluorogen-activating protein (FAP) biosensors.Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein.Curcumin inhibits tumor epithelial‑mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells
P2860
Q26741203-AF6DEE06-A8E8-4465-B694-F4088E364562Q26771894-C4D6B3F5-7586-479E-A03E-065DF75BEF1DQ26781915-E642A1DB-E357-45FC-A59C-A95CFB52FE32Q26998677-A5FD2081-7196-4411-9DAE-D40622D90258Q27011420-ED3D12F0-E66B-444E-BA8A-854E53F47666Q27307132-F4F91659-0C7A-45C2-A1BA-40E0AB7FCC47Q28085313-7A9BC8B7-D93E-4CCC-9C3F-17274CCB93B4Q28539620-6C5A7352-6BAC-41CB-8703-9910736A1347Q28542491-DB4F4153-01D7-453C-AF86-3F0DCEB6E1CDQ33416297-776C5A97-2887-48BA-9EDA-F9B5B9B3A835Q33562569-05513B1C-4A57-4266-8073-257B998BA0CCQ33577967-A12F8D18-C60B-4E42-864E-93E174BF1458Q33629970-D1CE0388-8481-41F7-955A-ED5B6BC16118Q33669451-D086AABD-D9D6-42C7-A7F0-0A5295C02246Q33703097-81731668-34D9-4838-80AD-2EE86B0DBCD0Q33758646-0534D07A-D7A1-4070-BC5C-86C70FFF1D57Q33920055-6DE5806F-CA71-4C21-B7E4-E91F6236E97DQ33993124-2DCE1166-6261-4FF0-9808-607448B2185AQ34476278-126150C2-A102-46F0-B932-84FAD8F2F5F9Q34631525-172ADB06-92C8-4FF1-A232-14551809C74FQ34978368-2A7786DC-0538-4004-BE0A-4DC11E7DC513Q34999307-2F6E5A12-98AC-4F2E-82C5-372E1A13F124Q35171366-8D91C80E-B888-4832-9E34-D3A2C94444F5Q35172310-9BC91461-31E2-4A4C-9AAE-6D1C6627F95BQ35201899-D43B8402-C614-49B4-B636-D811C6882D54Q35213463-28308383-4577-47F8-852C-16FEC31BBC52Q35227508-A11AD470-B6CB-4045-A64B-8F6D61CBAE67Q35284185-91DCF6DE-7C46-4DA5-83C9-F77AE46F31D2Q35483867-9FF0DD2C-43BF-413C-9059-540DD4917107Q35578377-FF055BAF-440C-4A4A-89A5-B6FB65F60DE2Q35727773-F984E01D-E22F-4631-A11D-573D56005981Q35732102-0CC94C2A-F0E6-4BFC-A6FF-E0EF381D9323Q35742364-F030FC87-2ED9-4675-BB45-2FA04FE8FA6CQ35918942-92024625-14AB-499C-A86F-8E50D8597817Q36042467-87F2FD84-CA1E-4BFF-A504-AF61BAAD868AQ36259458-348D6641-B334-400D-AFC9-26B61C0C6391Q36282884-1BF98C9F-2BAC-4D95-A8AD-18875F37455AQ36562089-7362D862-1460-4FDC-BA5E-B3581735A582Q36664240-5A255BF4-A0D7-4C44-996E-7C563252BFB1Q36738664-169DC9C1-447F-471A-BAA2-10310BBB42B8
P2860
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.
@en
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.
@nl
type
label
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.
@en
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.
@nl
prefLabel
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.
@en
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.
@nl
P2093
P2860
P356
P1476
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis.
@en
P2093
Claudia Peitzsch
Franziska Trautmann
Gennady D Telegeev
Leo Polishchuk
Monica Cojoc
P2860
P304
P356
10.2147/OTT.S36109
P407
P577
2013-09-30T00:00:00Z